Published in Transpl Infect Dis on June 01, 2001
The post-transplant lymphoproliferative disorder-a literature review. Pediatr Nephrol (2004) 1.92
Immune surveillance in the central nervous system. Nat Neurosci (2012) 1.63
Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog (2007) 1.29
Insights into the biology of primary central nervous system lymphoma. Curr Oncol Rep (2009) 0.95
Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease. J Clin Virol (2010) 0.84
The B subunit of Escherichia coli heat-labile enterotoxin enhances CD8+ cytotoxic-T-lymphocyte killing of Epstein-Barr virus-infected cell lines. J Virol (2003) 0.81
Is there diagnostic value in detection of immunoglobulin g antibodies to the epstein-barr virus early antigen? Biores Open Access (2012) 0.80
Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States. Am J Hematol (2014) 0.80
Post-transplant lymphoproliferative disorders: role of viral infection, genetic lesions and antigen stimulation in the pathogenesis of the disease. Mediterr J Hematol Infect Dis (2009) 0.78
Epstein-Barr Virus: Diseases Linked to Infection and Transformation. Front Microbiol (2016) 0.78
Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77
Post-transplant lymphoproliferative disorder presenting with skin ulceration in a renal transplant recipient who achieved sustained remission with rituximab therapy: A case report. Mol Clin Oncol (2016) 0.75
Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats. J Vet Pharmacol Ther (2013) 0.75
Hematopoietic stem cell transplantation after posttransplant lymphoproliferative disorder. J Korean Med Sci (2010) 0.75
Pulmonary re-occurrence of post-transplant lymphoproliferative disease with hypogammaglobulinaemia. Eur J Pediatr (2003) 0.75
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med (1989) 6.66
Induction of germ-line and mature C epsilon transcripts in human B cells stimulated with rIL-4 and EBV. J Immunol (1990) 1.25
Lytic, nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection. Can Med Assoc J (1984) 1.19
Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J Virol (2000) 1.17
Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220. J Virol (1996) 1.04
Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. J Med Virol (1989) 1.03
Allogeneic cellular gene therapy in hemoglobinopathies--evaluation of hematopoietic SCT in sickle cell anemia. Bone Marrow Transplant (2011) 1.01
Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders. J Infect Dis (1997) 0.93
Simultaneous congenital infection with Epstein-Barr virus and cytomegalovirus. N Engl J Med (1981) 0.93
Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft. Bone Marrow Transplant (2008) 0.92
Epstein-Barr virus induces Fas (CD95) in T cells and Fas ligand in B cells leading to T-cell apoptosis. Blood (1999) 0.91
Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection. J Virol (1987) 0.85
Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection. J Infect Dis (1997) 0.85
Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication. J Viral Hepat (2011) 0.83
Natural history of Epstein-Barr virus infection in a prospective pediatric cohort born to human immunodeficiency virus-infected mothers. J Infect Dis (1998) 0.82
Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease. Leuk Lymphoma (1996) 0.81
Atypical Epstein-Barr virus (EBV) latent protein expression in EBV-associated smooth muscle tumours occurring in paediatric transplant recipients. Histopathology (2008) 0.81
Effect of spironolactone and its metabolites on contractile property of isolated rat aorta rings. J Cardiovasc Pharmacol (2000) 0.81
Antibody responses to two Epstein-Barr virus (EBV) nuclear antigens (EBNA-1 and EBNA-2) during EBV primary infection in children born to mothers infected with human immunodeficiency virus. Clin Infect Dis (1996) 0.81
Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes. J Viral Hepat (2006) 0.80
Higher CD3(+) and CD34(+) cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia. Bone Marrow Transplant (2011) 0.80
Bacteroides species and gelatinase-producers in periodontal disease. J Can Dent Assoc (1982) 0.79
A solitary plasmacytoma of donor origin arising 14 years after kidney allotransplantation. Br J Haematol (1995) 0.77
The diagnosis of Epstein-Barr virus-associated polymorphic B cell lymphoma in immunocompromised patients: Review of methods. Can J Infect Dis (1991) 0.75
Radioimmunoprecipitation in the diagnosis of chronic active Epstein-Barr virus infection. J Med Virol (1994) 0.75
[In vivo and in vitro anti-viscosity activity of sobrerol]. Farmaco Prat (1981) 0.75
Acute aqueductal stenosis in a patient with Epstein-Barr virus infectious mononucleosis. Pediatr Infect Dis J (1994) 0.75
[OP.2B.09] PATIENTS WITH ADVANCED KIDNEY DISEASE AND NEPHROANGIOSCLEROSIS MIGHT NOT BENEFIT OF STRICT BLOOD PRESSURE CONTROL. J Hypertens (2016) 0.75
Diagnosis of cytomegalovirus (CMV) infection in pediatric transplant patients by the antigenemia, shell vial, and conventional culture assays performed on blood: correlation with CMV disease. Clin Diagn Virol (1996) 0.75
[A new method for the study of mucoproduction in rabbits]. Boll Chim Farm (1980) 0.75
Breast cancer surveillance in patients treated by radiotherapy for Hodgkin's lymphoma. Radiol Med (2012) 0.75